Filed: 11/15/2023ACC: 0001609251-23-000005
📋 What this filing means
KRENSAVAGE ASSET MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $271.6K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$271.6K
Total AUM (reported)
6.86M
Total Shares
Allocation by class
COM$271.6K100.0%
Portfolio Concentration
Top 3$128.2K47.2%
4–10$141.2K52.0%
11–25$2.2K0.8%
Top 3 weight
47.2%
Top 10 weight
99.2%
Voting Authority Distribution
Total shares with voting rights: 6.86M
Sole
Full voting authority
6.86M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
UNITED THERAPEUTICS CORP
SOLEShares201.22K
TypeSH
Market value$45.5K
16.73%
Sole
201.22K
Shared
0.00
None
0.00
EXELIXIS INC
SOLEShares1.90M
TypeSH
Market value$41.5K
15.28%
Sole
1.90M
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares160.48K
TypeSH
Market value$41.2K
15.19%
Sole
160.48K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares47.26K
TypeSH
Market value$38.9K
14.32%
Sole
47.26K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares906.06K
TypeSH
Market value$25.4K
9.34%
Sole
906.06K
Shared
0.00
None
0.00
CARDINAL HEALTH INC
SOLEShares291.32K
TypeSH
Market value$25.3K
9.31%
Sole
291.32K
Shared
0.00
None
0.00
TARO PHARMACEUTICAL INDUS
SOLEShares640.74K
TypeSH
Market value$24.2K
8.90%
Sole
640.74K
Shared
0.00
None
0.00
EMBECTA CORP
SOLEShares1.16M
TypeSH
Market value$17.5K
6.45%
Sole
1.16M
Shared
0.00
None
0.00
ENANTA PHARMACEUTICALS INC
SOLEShares735.10K
TypeSH
Market value$8.2K
3.02%
Sole
735.10K
Shared
0.00
None
0.00
EAGLE PHARMACEUTICALS INC
SOLEShares112.67K
TypeSH
Market value$1.8K
0.65%
Sole
112.67K
Shared
0.00
None
0.00
VANDA PHARMACEUTICALS INC
SOLEShares360.43K
TypeSH
Market value$1.6K
0.57%
Sole
360.43K
Shared
0.00
None
0.00
KODIAK SCIENCES INC
SOLEShares342.31K
TypeSH
Market value$616.00
0.23%
Sole
342.31K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
UNITED THERAPEUTICS CORPSOLE | COM | 201.22K | SH | $45.5K 16.73% | 201.22K | 0.00 | 0.00 |
EXELIXIS INCSOLE | COM | 1.90M | SH | $41.5K 15.28% | 1.90M | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 160.48K | SH | $41.2K 15.19% | 160.48K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 47.26K | SH | $38.9K 14.32% | 47.26K | 0.00 | 0.00 |
ALKERMES PLCSOLE | COM | 906.06K | SH | $25.4K 9.34% | 906.06K | 0.00 | 0.00 |
CARDINAL HEALTH INCSOLE | COM | 291.32K | SH | $25.3K 9.31% | 291.32K | 0.00 | 0.00 |
TARO PHARMACEUTICAL INDUSSOLE | COM | 640.74K | SH | $24.2K 8.90% | 640.74K | 0.00 | 0.00 |
EMBECTA CORPSOLE | COM | 1.16M | SH | $17.5K 6.45% | 1.16M | 0.00 | 0.00 |
ENANTA PHARMACEUTICALS INCSOLE | COM | 735.10K | SH | $8.2K 3.02% | 735.10K | 0.00 | 0.00 |
EAGLE PHARMACEUTICALS INCSOLE | COM | 112.67K | SH | $1.8K 0.65% | 112.67K | 0.00 | 0.00 |
VANDA PHARMACEUTICALS INCSOLE | COM | 360.43K | SH | $1.6K 0.57% | 360.43K | 0.00 | 0.00 |
KODIAK SCIENCES INCSOLE | COM | 342.31K | SH | $616.00 0.23% | 342.31K | 0.00 | 0.00 |